US 10023544
Heterocyclic compound
granted A61PA61P3/00A61P3/04
Quick answer
US patent 10023544 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P3/00, A61P3/04, A61P3/10, A61P43/00